EirGenix Inc. (TPEX:6589)
Taiwan
· Delayed Price · Currency is TWD 71.50
-0.50 (-0.69%)
Apr 2, 2025, 10:36 AM CST
EirGenix Revenue
In the year 2024, EirGenix had annual revenue of 1.01B TWD, down -1.34%. EirGenix had revenue of 294.64M in the quarter ending December 31, 2024, a decrease of -35.47%.
Revenue
1.01B
Revenue Growth
-1.34%
P/S Ratio
21.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.01B | -13.69M | -1.34% |
| Dec 31, 2023 | 1.02B | -458.36M | -30.95% |
| Dec 31, 2022 | 1.48B | -216.34M | -12.75% |
| Dec 31, 2021 | 1.70B | 625.52M | 58.36% |
| Dec 31, 2020 | 1.07B | 595.75M | 125.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Polaris Group | 107.00M |